Goodwin Names 57 New Partners

Global law firm Goodwin today announced that 58 lawyers have been elected to the firm’s partnership, effective immediately.

“Our newest partners are an immensely talented group who have demonstrated dedication to our clients by excelling at high-stakes litigation and dispute resolution, providing world class regulatory and advisory services, and executing complex transactions globally across our clients' industries of focus and at the intersection of capital and innovation,” said Rob Insolia, Goodwin’s Chairman. “We are thrilled to welcome this class — the largest in our firm’s history.”

Goodwin congratulates:

	Tessa Agar (Private Equity, London) advises on all aspects of corporate law, with a focus on mid-market private equity transactions, cross-border mergers and acquisitions, and growth equity and venture capital investments. She is experienced in a variety of industries, including technology, healthcare, telecommunications, financial services, food, and consumer products.
	Yasin Akbari (Life Sciences, Boston) specializes in complex transactions in the life sciences industry, with a focus on mergers and acquisitions, royalty-based financings, product development financings, strategic investments, and capital markets transactions. She also counsels company leadership and boards on corporate governance, securities law compliance, and ongoing corporate strategy and risk management.
	Steven Argentieri (Intellectual Property, Boston) advises on transactional intellectual property law, including issues involving IP protection strategies, patent prosecution and opinions, freedom to operate analyses, open-source software licensing and compliance, technology and life sciences licenses and commercial agreements, and IP matters in M&A, IPOs, and investment transactions.
	Brett Burka (Private Equity, New York) advises emerging and late-stage companies as well as venture capital, growth equity, and private equity investors on a variety of transactions in the technology sector, including mergers and acquisitions, venture capital financings, direct secondaries, tender offers, strategic collaborations, expansions, and exits.
	Alexander Callen (Financial Industry, Washington, D.C.) focuses on the convergence of banking and financial technology and represents banks, fintech companies, holding companies, and investors in a variety of regulatory, transactional, and corporate governance matters.
	Edwina Clarke (Appellate Litigation, Boston) focuses on appellate and complex civil litigation, and she has experience in a wide range of areas including ERISA litigation, patent litigation, and constitutional law. She has authored briefs in numerous trial and appellate courts throughout the United States, including the U.S. Supreme Court.
	Erin Claywell (Real Estate Industry, Boston) represents owners, operators, and investors—including REITs, private and public institutional investors, investment managers, pension funds, and other tax-exempt investors—in complex commercial real estate matters. She specializes in joint ventures, debt financings, acquisitions and dispositions, development, and leasing.
	Marishka DeToy (Life Sciences, Boston) represents issuers and underwriters in a range of capital markets transactions, including initial public offerings, follow-on public offerings, ATMs, and public and private placements of equity and debt securities. She also represents public and private companies in ongoing corporate governance matters and SEC reporting.
	Tucker DeVoe (Securities Litigation, Boston) focuses on securities litigation and complex commercial disputes in the life sciences, healthcare, private equity, and venture capital sectors, including class action defense, M&A litigation, corporate governance matters, antitrust litigation, and government investigations and litigation.
	Christopher Edwab (Private Equity, Santa Monica) advises private equity sponsors, portfolio companies, and other clients on a variety of domestic and cross-border transactional matters, including acquisitions and divestitures, leveraged buyouts, growth equity investments, and joint ventures, as well as general company matters.
	Joshua Eisenson (Technology, New York) advises founders and executive teams of emerging growth companies throughout the corporate lifecycle and supports their commercial, strategic and legal needs on a range of critical transactions, including formation planning, venture capital financings, M&A, and corporate governance. He also represents venture capital and other strategic investors on their investments and portfolio dispositions.
	Raymond Fang (Real Estate Industry, London) focuses on U.K. and Pan-European real estate M&A and joint ventures. He acts on transactions across real estate asset classes and structures ranging from single trophy assets to complex, multi-jurisdictional portfolios. He is a part of the Goodwin Proptech and Propsci initiatives, and a London Committee on Racial and Ethnic Diversity leader.
	Catharina Förster (Real Estate Industry, Frankfurt) focuses on acquisitions and sales of real estate properties, including asset and share deals, commercial leases, and other property-related transactions and contracts.
	Kristin Gerber (Technology, Boston) represents private companies in all stages of growth as well as venture capital funds, private equity funds, and strategic acquirers in both domestic and cross-border M&A transactions and venture capital financings. Focusing on the technology industry, with expertise in software, healthcare, and financial services, she also has experience in the biotechnology and medical device sectors.
	William Goldberg (Real Estate Industry, Boston) focuses on corporate and securities matters, including public and private securities offerings, securities law compliance, corporate governance, executive compensation, and other general corporate law matters.
	Simone Greenspan (Private Equity, New York) focuses on representing private equity, growth equity, and venture capital funds; portfolio companies; and other private companies on a range of matters, including leveraged buyouts, acquisitions and divestitures, joint ventures, recapitalizations, tender offers, fundraising, and general corporate and securities law matters.
	Shannyn Henke (Life Sciences, Boston) represents biotechnology, pharmaceutical, medical device, and other life sciences companies in connection with commercial, M&A, and intellectual property transactions, including matters involving pre-clinical, clinical, manufacturing, and commercial contracts, as well as complex strategic collaboration, co-development, licensing, and partnering transactions.
	Christina Hennecken (ERISA and Consumer Finance Litigation, Washington, D.C.) represents financial services companies in consumer class actions, government enforcement proceedings and investigations, and complex civil litigation involving the Employee Retirement Income Security Act, the Consumer Financial Protection Act, and other federal and state consumer financial protection laws
	Jake Herman (Private Equity, New York) advises clients on broad-based general corporate and transactional matters with a particular focus on U.S. and cross-border M&A, private equity, growth equity, and venture capital transactions.
	Margaret Hickey (Technology, Boston) advises on transactions in the technology sector, with a primary focus on mergers, acquisitions, venture financings, and private equity investments, as well as other general corporate matters in a broad range of industries.
	Timothy Holahan (Employment, Boston) advises on the employment-related aspects of corporate transactions; advocates for clients in employment-related disputes and restrictive covenant matters; counsels clients on employment best practices, including with respect to hiring, retention, compensation, and termination; and assists with devising and implementing employment-related policies, training, and practices.
	Richard Hughes (Leveraged Finance, London) advises private equity sponsors, corporates, and financial institutions on a range of finance matters, with a primary focus on leveraged and cross-border acquisition finance, as well as refinancing matters.
	Hayes P. Hyde (White Collar and Securities Litigation, San Francisco) focuses on securities litigation and white-collar criminal investigations; intellectual property, trade secret, and employee mobility litigation; and complex federal and state civil litigation.
	Daniel Isaacs (Technology, Boston) advises emerging companies and investors throughout the corporate lifecycle, focusing on venture capital and growth equity financings, M&A, public offerings, and general corporate representation. His practice spans a variety of technology and life sciences industries, including digital health, healthcare, alternative energy, clean technologies, AI and machine learning, cybersecurity, and fintech.
	Kizzy Jarashow (Financial Restructuring, New York) represents debtors, lenders, creditors, equity holders, sponsors, special situation investors, and other stakeholders in all aspects of complex corporate restructurings, including Chapter 11 cases, out-of-court restructurings and work-outs, lending transactions, liability management, distressed debt investments, and distressed sale transactions.
	Adam Kopald (Real Estate Industry, New York) represents real estate investment funds, REITs, institutional investors, developers, and other owners and operators of commercial real estate in complex matters, including acquisitions and dispositions, joint ventures, debt financings, preferred equity, development, and restructurings, with a focus on hospitality, industrial, commercial, office, and multi-family assets.
	Felix Krüger (Tax, Real Estate Funds, Frankfurt) counsels on the tax aspects of private equity and real estate transactions, with a primary focus on tax advice over the lifecycle of real estate investments.
	Julian Landau-Sabella (Private Equity, Santa Monica) advises emerging and late-stage companies as well as venture capital, growth equity, and private equity investors on a variety of corporate transactions, including mergers and acquisitions, venture capital financings, and strategic collaborations.
	Keith Levenberg (Consumer Finance Litigation, Washington, D.C.) specializes in the defense of class actions and other high-stakes lawsuits for banks and other financial service providers. He litigates Fair Housing Act challenges to loan originations, class actions arising from mortgage modification programs, and other lawsuits implicating consumer protection laws.
	Alexandra Lu (Intellectual Property Litigation, Boston) focuses on patent infringement litigation and complex arbitration disputes in the biotechnology and pharmaceutical sectors, with a focus on matters involving biosimilars and biologics. She represents clients through all phases of litigation, including pre-suit patent analysis, trial, and appeal.
	Jennifer Burns Luz (Securities Litigation, Boston) focuses her securities and complex commercial litigation practice on class action, and derivative litigation defense, including fiduciary duty claims, corporate governance matters, M&A-related litigation, shareholder disputes, and government and internal investigations.
	Catherine Magazu (Life Sciences, Boston) represents public and private companies in the pharmaceutical, biotechnology, and medical device industries, advising on start-up and formation matters, venture capital financings, initial public offerings, and other capital markets transactions, strategic investments, and general corporate matters.
	Tiffany Mahmood (Intellectual Property Litigation, New York) focuses on patent matters involving pharmaceuticals, chemicals, and biotechnology, and represents companies in all stages of patent litigation, from pre-suit investigation through trial.
	Gabriela Morales-Rivera (Life Sciences, Boston) represents public and private companies throughout the corporate lifecycle, including in startup and formation matters, venture capital financings, initial public offerings and other capital markets transactions, ongoing SEC compliance, strategic investments, and other complex transactions.
	Bhargavi Mudakavi (Real Estate Industry, London) advises investment managers and a range of investors on closed and open-ended funds, co-investments, and segregated accounts in the real estate and private equity sectors, including matters involving carried interest structures and the establishment of fund manager platforms. She also advises on joint ventures and other corporate real estate transactions.
	Dennis O'Reilly (Private Equity, Washington, D.C.) represents clients in a variety of corporate matters, with a focus on complex U.S. and cross-border growth equity investments, mergers and acquisitions, leveraged buyouts, venture capital financings, direct secondary and tender offer transactions, and general business counseling.
	Bibek Pandey (ERISA & Executive Compensation, Washington, D.C.) advises global banks, broker-dealers, asset managers, and fund service providers on matters relating to the investment of employee benefit capital. He focuses on investment funds, general asset management, bank/broker-dealer issues, public plans, prohibited transaction exemptions, and government investigations.
	Tevia Pollard (Technology, Boston) represents public and private companies in mergers and acquisitions. She also advises public companies and their boards of directors on securities offerings, financings, corporate governance
	Andrew Pollock (Private Equity, London) focuses on the establishment of private equity, debt, venture, and infrastructure funds. He advises investment managers and institutional investors across a range of strategies, including private equity and direct credit mid-market investment, longer term infrastructure investment, fund of funds and secondary investing. He also advises on the structuring of investment management platforms and house carried interest and co-investment arrangements.
	Lindsay Reed (Private Equity, Boston) represents financial sponsors and their portfolio companies in the healthcare, manufacturing, consumer, and technology industries in complex mergers, acquisitions, joint ventures, dispositions, and restructurings.
	Danielle Reyes (Financial Industry, Washington, D.C.) co-chairs the firm’s ESG & Impact group and provides regulatory compliance advice with a focus on non-financial reporting, investor due diligence, financial inclusion, the Community Reinvestment Act, and corporate social responsibility programs.
	Eric Romeo (Intellectual Property Litigation, Boston) advises on intellectual property matters in the pharmaceutical, chemical, biological, and high-tech industries, with a primary focus on pharmaceutical patent litigation involving the Hatch-Waxman Act.
	Christine Sama (Commercial Litigation, New York) represents financial institutions and service providers in complex commercial disputes, including class action, fraud, and contract matters. She also represents technology companies, private equity firms, venture capital firms, and other private companies in business disputes, including acquisition, partnership, and founder disputes.
	Justin Smith (Technology, Los Angeles) advises on M&A, venture finance, and corporate governance, with a focus on semiconductor, e-commerce, blockchain, cybersecurity, marketing technology, and life sciences industries. His cross-border M&A experience includes transactions involving China, Japan, Singapore, Canada, Mexico, the U.K., France, Australia, the Netherlands, Sweden, Switzerland, and Germany.
	Ai Tajima (Risk Management & Insurance, Boston) advises on insurance matters and specializes in the optimal use of R&W, W&I, and other transactional insurance in connection with M&A and post-closing claims. She is experienced in U.S. and international buy-side and sell-side deals for private equity, corporate, real estate, and other clients across various sectors, deal sizes, and transaction types.
	Adam Thatcher (Technology, Cambridge) specializes in venture capital financings and M&A transactions, focusing on emerging growth companies and venture capital investors in the fintech, life sciences, healthcare, and technology sectors.
	Steven Tjoe (Life Sciences, Washington, D.C.) advises clients in the medical device, diagnostic, pharmaceutical, and biotechnology sectors on FDA matters, including regulatory strategy and compliance.
	Kenny Walker-Durrant (Life Sciences, London) advises emerging growth companies and venture capital firms, with a particular focus on M&A transactions, growth equity investments, and venture capital financings in the life sciences and technology sectors.
	Qingyi (Ree) Wang (Private Investment Funds, Silicon Valley) advises and represents asset managers in connection with the structuring, formation, management, and regulatory compliance of venture capital and other private equity funds, as well as with day-to-day legal and operational challenges faced by fund sponsors.
	Joshua Weinger (Intellectual Property Litigation, Boston) advises on patent matters and litigates patent infringement suits in the biotechnology, pharmaceutical, medical device, and high-tech sectors, with a focus on matters involving biosimilars and biologics.
	Grace Wirth (ERISA & Executive Compensation, Washington D.C.) advises public and private companies, venture capital and private equity funds, and members of management on executive compensation and benefits issues that arise in corporate transactions. She also counsels on employment and severance arrangements, equity-based programs, tax compliance matters, and SEC rules governing executive compensation disclosure and reporting.
	Benjamin Yeoh (Private Investment Funds, London) represents private equity, venture, infrastructure, and real estate fund managers on the structuring, establishment, operation, and fundraising of private investment funds, as well as on co-investments, separate managed account arrangements, carry and co-investment schemes. He also advises investors on specific fund investments.

 

The firm also announced the appointment of two lawyers from Goodwin’s Office of the General Counsel as national partners of Goodwin Procter (UK) LLP.
 
Goodwin congratulates: